The EFMC Young Medicinal Chemist Symposium is an initiative of the European Federation for Medicinal Chemistry (EFMC). After a succesful first edition organised in Lisbon in September 2014 and a second edition organised in Antwerp in September 2015, the third edition will be organised in connection with the XXIV EFMC International Symposium on Medicinal Chemistry (EFMC-ISMC 2016) that will take place in Manchester (United Kingdom) from August 28 until September 1, 2016.
This short symposium has the aim of:
The Programme of the 3rd EFMC Young Medicinal Chemist Symposium will include:
The EFMC Young Medicinal Chemist Symposium is open to any scientist interested by the topics related to Medicinal Chemistry.
Stay tuned efmc-ymcs.org
Join us for the GMP Summit 2016 Conference!!!! The biggest conference gathering of the global pharma manufacturing industry, attracting attendees from around the globe.
The program agenda provides a unique forum for pharmaceutical executives from around the world to network and hear world-renowned experts discussing the latest insight into the international Intellectual Property, Business Development, Bioequivalence, Regulatory/ Legal Affairs, Research and Development and pharmacovigilance from pharma and biopharma field concerning the pharmaceutical manufacturing sector.
Good Manufacturing Practice (GMP) is a system for ensuring that products are consistently produced and controlled according to quality standards. It is designed to minimize the risks involved in any pharmaceutical production that cannot be eliminated through testing the final product. GMP covers all aspects of production; from the starting materials, premises and equipment to the training and personal hygiene of staff. Advanced studies are being made to improvise quality of products, reduce safety risk and cost, and enhance international credibility and public image and many more.
In recent years, therapeutic peptides have been developed for the treatment of several diseases such as cancer, metabolic disorders, nervous system disorders and gastrointestinal disorders, among others. As a result of their efficacy treating a huge array of conditions, further research has been done to develop a rich pipeline of novel peptides. SMi’s 3rd annual Peptides event provides the perfect platform to discuss the latest innovations and development in the peptides industry and explore a number of pressing issues such as the use of Cell Penetrating Peptides (CPP), the challenges involved with oral peptides and novel technologies, and many more.Visit http://www.peptidesevent.com/bioscreening to view the conference agenda and to benefit from the best price through online registration.
SMi Group is thrilled to present the 3rd annual Allergies conference, taking place on 6th & 7th July 2016 in Central London, UK. Aimed at an audience of senior scientists and allergy specialists involved in immunology and drug research, Allergies 2016 will provide the perfect platform to discuss pioneering clinical developments and the next generation of allergy therapeutics.
Created with a top panel of industry thought leaders, this year's event will look to capture expert insight by honing in on new pathways with novel vaccines and adjuvants, immunoassays for molecular diagnostic’s, paediatric allergies, personalised treatment, allergen specific immunotherapies, plus much more.'
Through strategic direction and regulatory guidance, the programme will look to strengthen knowledge in topics such as biomarker validation, and arm attendees with the key requirements and tools for successful trials and study outcomes.
For further information or to register, visit the website at http://www.allergies-event.com/bioscreening
SMi is thrilled to announce the return of its 4th annual conference, Lyophilisation Europe, taking place on 4th and 5th July in London, UK. With the rising risk of contamination and the need for improved formulation methods of biological products, robust capabilities in lyophilisation and freeze drying methods have become critical for process efficiency and commercial success whilst maintaining drug quality and stability.
Innovation and efficiency is requested at every level making Lyophilisation Europe 2016, the perfect platform to strengthen knowledge in key principles such as PAT and QbD, whilst staying at the forefront of technological breakthroughs to adapt to a competitive growing industry.
Aimed at an audience of Senior Scientists and Heads of Pharmaceutical Engineering, Lyophilisation Europe 2016 will provide a focal point for the industry to discuss the latest advancements in pharmaceutical freeze drying, welcoming expertise from the likes of Boehringer Ingelheim, GSK and Sanofi.
Page 1 of 36
© 2014 Bioscreening.com